The Breast
Издатель: Elsevier · ISSN 0960-9776 · 37 статей
- Factors associated with interval breast cancer in screened populations: a systematic review
- Editorial Board
- Clinical and AI-derived Digital Pathology Features of Invasive Lobular and Ductal Carcinoma for Predicting 5-Year Recurrence or Metastasis
- Regional nodal irradiation might not improve locoregional recurrence-free survival in ypN0 breast cancer patients undergoing neoadjuvant chemotherapy
- Reirradiation After Repeat Breast Conserving Treatment: Contemporary Evidence, Technical Approaches, and Expert Recommendations
- 8th International consensus guidelines for the management of advanced breast cancer (ABC8 guidelines)
- Knowledge gaps and future perspectives for the definition, diagnostics and treatment of isolated locoregional recurrent breast cancer
- Impact of multidisciplinary tumor meetings on clinical outcomes, treatment concordance, and guideline adherence in breast cancer: a systematic review with emphasis on older patients
- Prognostic role of thymidine kinase 1 activity in hormone receptor positive metastatic breast cancer. A systematic review and meta-analysis
- Surgery-first versus neoadjuvant chemotherapy in stage I (cT1c) triple-negative breast cancer: A critical reappraisal
- Current state and future potential of radiopharmaceutical therapy in breast cancer
- Longitudinal trajectories of menopausal symptoms in women receiving endocrine therapy for breast cancer compared with natural menopause
- Impact of old age, comorbidity, and polypharmacy on adjuvant endocrine therapy for patients with early-stage breast cancer
- Use of prepectoral polyurethane coated implants in the setting of radiotherapy: the OPBC-09 PRExRT retrospective cohort study
- Incidence and mortality of breast cancer among adolescent and young adult women worldwide in 2022 and projections for 2040: Implications for surgery
- Real-world use of pembrolizumab in early-stage triple-negative breast cancer: Data from the French Early Access Program
- Cost-effectiveness of abbreviated breast MRI and contrast-enhanced mammography for women with extremely dense breasts in a national breast cancer screening program: a micro-simulation study
- Pembrolizumab plus chemotherapy followed by pembrolizumab in participants in Asia with early triple-negative breast cancer: An updated subgroup analysis of the KEYNOTE-522 randomized clinical trial
- Which quality of life issues are important to patients with metastatic breast cancer: Phase 1 and 2 development of European Organisation for Research and Treatment of Cancer metastatic breast cancer module (EORTC QLQ-MBR)
- Transcriptomic signatures of mind-body transformations therapy in breast cancer: Downregulation of the interferon signaling pathway
- Early termination of clinical trials enrolling patients with breast cancer: Reasons, determinants, and temporal patterns
- Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study
- Performance of large language models in ambiguous treatment scenarios of early breast cancer
- Tucatinib, trastuzumab, and capecitabine as second- or third-line therapy after trastuzumab deruxtecan in HER2-positive metastatic breast cancer: A multicenter retrospective study in France
- Analysis of outcomes of nab-paclitaxel compared to other taxanes in early breast cancer: A study revealing the critical role of calendar-time bias in real-world drug comparisons
- Risk factors of immune-related adverse events in patients with early-stage breast cancer: Findings from a multi-institutional retrospective study
- Subtype-specific screen-detected and interval breast cancer rates in population screening: a BreastScreen Queensland cohort study
- Effect of dose-dense adjuvant chemotherapy in patients with node-positive early breast cancer according to estrogen receptor levels: an exploratory analysis of the GIM2 trial
- Impact of anti-HER2 therapies on potentially avoidable deaths from stage II and III HER2-positive breast cancer in the Brazilian public healthcare system
- Prospective assessment of incomplete ovarian suppression in breast cancer using LC-MS/MS and immunoassays for estradiol